TrialInvestigational new drugs2009
Docetaxel and epirubicin salvage regimen in relapsed anthracycline-sensitive metastatic breast cancer patients after anthracycline-containing adjuvant therapy.
Jae Hong Seo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.